Nicolann Hedgpeth
Family · Irvine, CANPI 1235118993
Payments from drug & device makers
Across 83 payments — averaging $52.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$803
- Johnson & Johnson$662
- AstraZeneca$416
- Incyte Corporation$342
- Regeneron Healthcare Solutions, Inc.$307
- Takeda Pharmaceuticals U.S.A., Inc.$183
- plus $2K from 23 others
What the payments were for
- Food & beverage$4,17696%
- Education$1644%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 11 | $803 |
| Johnson & Johnson | 7 | $662 |
| AstraZeneca(2 entities) | 7 | $416 |
| Incyte Corporation | 6 | $342 |
| Regeneron Healthcare Solutions, Inc. | 4 | $307 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $183 |
| Daiichi Sankyo Inc. | 2 | $155 |
| Amgen | 2 | $138 |
| Astellas Pharma US Inc | 4 | $130 |
| Lilly USA, LLC | 5 | $130 |
| Dendreon Pharmaceuticals LLC | 2 | $126 |
| Jazz Pharmaceuticals Inc. | 1 | $124 |
| Karyopharm Therapeutics Inc. | 1 | $121 |
| Gilead | 1 | $96 |
| Novartis | 5 | $96 |
| Taiho Oncology, Inc. | 3 | $90 |
| AbbVie | 2 | $57 |
| Myovant Sciences Inc. | 2 | $52 |
| Pfizer | 2 | $46 |
| Eisai Inc. | 2 | $46 |
| Boehringer Ingelheim | 2 | $45 |
| Merck | 2 | $41 |
| Bayer | 1 | $22 |
| Genentech USA, Inc. | 1 | $22 |
| Sanofi | 1 | $20 |
| Mirati Therapeutics, Inc. | 1 | $20 |
| Morphosys, US Inc. | 1 | $19 |
| Abbott | 1 | $17 |
| Array Biopharma Inc | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,340 in reported general payments places this provider in the 90th percentile of 10,634 family providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Imatinib Mesylate | 14 | $46,638 |
Paid to pharmacies, not to this prescriber.
Other family in Irvine
- Lori RobertsonChino Hills$475K
- Annette ShonLos Angeles$406K
- Nancy GardettoSan Diego$394K
- Lisa HigginsHanford$311K
- Jennifer TougasBakersfield$302K
- Kim SchaferSacramento$288K
- Dawn MeyerSan Diego$270K
- Jennifer KangCerritos$255K
- Jenine StoneEscondido$231K
- Erin DwyerSan Diego$189K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.